Takeda’s iPS Cell Deal Potential Game Changer in Drug Research

Takeda CEO Christophe Weber (left), CiRA Director Shinya Yamanaka at Tokyo Press Conference Takeda Pharmaceutical’s research collaboration deal on iPS cells with a Kyoto University institute led by Nobel laureate Shinya Yamanaka could change the way drug research is conducted,...read more